David Gionco Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Gionco.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Gionco. David Gionco is Group Vice President, CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and Group VP & CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and Group VP, CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and VP, CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and Chief Accounting Officer in STEMLINE THERAPEUTICS INC ($STML).
Latest Insider Trading Transactions of David Gionco
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Option Exercise | D | 4.12 | 45,102 | 185,820 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | U | 0.00 | 327,878 | 0 | 0 | 327.9 K to 0 (-100.00 %) |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 45,000 | 0 | 327,878 | 282.9 K to 327.9 K (+15.91 %) |
| Apr 03 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 4.79 | 11,524 | 55,200 | 282,878 | 294.4 K to 282.9 K (-3.91 %) |
| Mar 20 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 3.88 | 2,849 | 11,054 | 316,885 | 319.7 K to 316.9 K (-0.89 %) |
| Mar 20 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 3.88 | 2,849 | 11,054 | 316,885 | 319.7 K to 316.9 K (-0.89 %) |
| Mar 13 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 4.92 | 8,846 | 43,522 | 319,734 | 328.6 K to 319.7 K (-2.69 %) |
| Mar 13 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 5.08 | 5,011 | 25,456 | 328,580 | 333.6 K to 328.6 K (-1.50 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 6.43 | 9,147 | 58,815 | 333,591 | 342.7 K to 333.6 K (-2.67 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 6.43 | 9,147 | 58,815 | 333,591 | 342.7 K to 333.6 K (-2.67 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 107,317 | 0 | 342,738 | 235.4 K to 342.7 K (+45.59 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 107,317 | 0 | 342,738 | 235.4 K to 342.7 K (+45.59 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 10.48 | 197 | 2,065 | 235,421 | 235.6 K to 235.4 K (-0.08 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 10.75 | 1,511 | 16,243 | 235,618 | 237.1 K to 235.6 K (-0.64 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 10.97 | 2,388 | 26,196 | 237,129 | 239.5 K to 237.1 K (-1.00 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 10.58 | 421 | 4,454 | 239,517 | 239.9 K to 239.5 K (-0.18 %) |
| May 17 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 15,000 | 0 | 239,938 | 224.9 K to 239.9 K (+6.67 %) |
| Mar 15 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 11.05 | 530 | 5,857 | 224,938 | 225.5 K to 224.9 K (-0.24 %) |
| Mar 15 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 11.11 | 13,492 | 149,896 | 225,468 | 239 K to 225.5 K (-5.65 %) |
| Mar 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 11.32 | 1,381 | 15,633 | 238,960 | 240.3 K to 239 K (-0.57 %) |
| Mar 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 11.32 | 1,381 | 15,633 | 238,960 | 240.3 K to 239 K (-0.57 %) |
| Feb 27 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 12.03 | 8,563 | 103,013 | 240,341 | 248.9 K to 240.3 K (-3.44 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 9,009 | 0 | 248,904 | 239.9 K to 248.9 K (+3.76 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 69,550 | 0 | 239,895 | 170.3 K to 239.9 K (+40.83 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 15,000 | 0 | 170,345 | 155.3 K to 170.3 K (+9.66 %) |
| Mar 14 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 18.28 | 1,525 | 27,877 | 180,684 | 182.2 K to 180.7 K (-0.84 %) |
| Mar 14 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 17.20 | 7,658 | 131,718 | 182,209 | 189.9 K to 182.2 K (-4.03 %) |
| Mar 09 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 37,592 | 0 | 189,867 | 152.3 K to 189.9 K (+24.69 %) |
| Mar 09 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 16.56 | 1,413 | 23,399 | 152,275 | 153.7 K to 152.3 K (-0.92 %) |
| Feb 28 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 17.26 | 4,584 | 79,120 | 153,554 | 158.1 K to 153.6 K (-2.90 %) |
| Feb 28 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 17.61 | 4,400 | 77,484 | 158,138 | 162.5 K to 158.1 K (-2.71 %) |
| Jan 19 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 13.43 | 4,250 | 57,078 | 162,538 | 166.8 K to 162.5 K (-2.55 %) |
| Jan 19 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 13.43 | 4,250 | 57,078 | 162,538 | 166.8 K to 162.5 K (-2.55 %) |
| Mar 09 2017 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 70,299 | 0 | 166,213 | 95.9 K to 166.2 K (+73.29 %) |
| Mar 09 2017 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 8.13 | 1,116 | 9,073 | 95,914 | 97 K to 95.9 K (-1.15 %) |
| Mar 01 2017 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 7.01 | 2,986 | 20,932 | 96,906 | 99.9 K to 96.9 K (-2.99 %) |
| Mar 01 2017 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 6.97 | 3,500 | 24,395 | 99,892 | 103.4 K to 99.9 K (-3.39 %) |
| Jan 24 2017 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 11.46 | 3,593 | 41,176 | 103,392 | 107 K to 103.4 K (-3.36 %) |
| Mar 10 2016 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 5.32 | 1,148 | 6,107 | 106,467 | 107.6 K to 106.5 K (-1.07 %) |
| Feb 26 2016 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Option Exercise | A | 4.12 | 144,261 | 594,355 | 144,261 | |
| Feb 26 2016 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 72,023 | 0 | 107,267 | 35.2 K to 107.3 K (+204.36 %) |
| Jan 21 2016 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 4.69 | 46 | 216 | 35,244 | 35.3 K to 35.2 K (-0.13 %) |
| Jan 21 2016 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 4.82 | 3,171 | 15,284 | 35,290 | 38.5 K to 35.3 K (-8.24 %) |
| Mar 10 2015 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Option Exercise | A | 15.75 | 32,841 | 517,246 | 32,841 | |
| Mar 10 2015 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 11,569 | 0 | 38,258 | 26.7 K to 38.3 K (+43.35 %) |
| Jan 27 2011 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP & CFO | Sell | S | 10.00 | 2,032 | 20,320 | 42,735 | 44.8 K to 42.7 K (-4.54 %) |
| Jan 27 2011 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP & CFO | Grant | A | 10.03 | 73 | 732 | 44,767 | 44.7 K to 44.8 K (+0.16 %) |
| Jan 27 2011 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP & CFO | Grant | A | 11.95 | 60 | 717 | 44,694 | 44.6 K to 44.7 K (+0.13 %) |
| Jan 27 2011 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP & CFO | Grant | A | 10.23 | 71 | 727 | 44,634 | 44.6 K to 44.6 K (+0.16 %) |
| Jan 27 2011 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP & CFO | Grant | A | 11.45 | 144 | 1,649 | 44,563 | 44.4 K to 44.6 K (+0.32 %) |
| Dec 30 2010 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP & CFO | Sell | S | 11.87 | 1,536 | 18,233 | 44,419 | 46 K to 44.4 K (-3.34 %) |
| Sep 20 2010 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group Vice Presiden ... | Payment of Exercise | F | 20.27 | 8,118 | 164,552 | 45,955 | 54.1 K to 46 K (-15.01 %) |
| Sep 20 2010 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group Vice Presiden ... | Grant | A | 20.27 | 22,918 | 464,548 | 54,073 | 31.2 K to 54.1 K (+73.56 %) |
| Feb 17 2010 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP & CFO | Sell | S | 13.81 | 1,253 | 17,300 | 31,155 | 32.4 K to 31.2 K (-3.87 %) |
| Feb 11 2010 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP & CFO | Sell | S | 12.77 | 2,037 | 26,003 | 32,408 | 34.4 K to 32.4 K (-5.91 %) |
| Dec 22 2009 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | VP, CFO | Sell | S | 12.95 | 1,511 | 19,561 | 34,445 | 36 K to 34.4 K (-4.20 %) |
| Dec 22 2009 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | VP, CFO | Grant | A | 11.35 | 61 | 692 | 35,956 | 35.9 K to 36 K (+0.17 %) |
| Sep 15 2009 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP, CFO | Option Exercise | M | 4.32 | 7,500 | 32,400 | 0 | |
| Sep 15 2009 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP, CFO | Sell | S | 15.95 | 7,500 | 119,625 | 35,895 | 43.4 K to 35.9 K (-17.28 %) |
| Sep 15 2009 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP, CFO | Buy | M | 4.32 | 7,500 | 32,400 | 43,395 | 35.9 K to 43.4 K (+20.89 %) |
| Sep 15 2009 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP, CFO | Sell | S | 15.36 | 10,887 | 167,224 | 35,895 | 46.8 K to 35.9 K (-23.27 %) |
| Sep 15 2009 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP, CFO | Grant | A | 11.35 | 62 | 704 | 46,782 | 46.7 K to 46.8 K (+0.13 %) |
| Sep 15 2009 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP, CFO | Grant | A | 5.40 | 129 | 696 | 46,720 | 46.6 K to 46.7 K (+0.28 %) |
| Sep 15 2009 | SVNT | SAVIENT PHARMACEUT ... | Gionco David | Group VP, CFO | Grant | A | 3.67 | 377 | 1,384 | 46,591 | 46.2 K to 46.6 K (+0.82 %) |
Page: 1